Skip to main content
Premium Trial:

Request an Annual Quote

NIH Launches Medical Research Scholars Program

Premium

The National Institutes of Health is launching a new program for medical and dental students who'd like to gain "research experiences with intramural investigators from across NIH in basic science laboratories, and in clinical and translational research conducted at the NIH Clinical Center." Through a partnership with the Foundation for the National Institutes of Health and with support from Pfizer and the Howard Hughes Medical Institute, NIH plans to admit around 40 students to its Medical Research Scholars Program beginning September 2012, though the agency says its "goal is to accept up to 70 students as the program grows." Students accepted to the program will receive a stipend and other support, such as for travel to scientific meetings. "There will be a curriculum in clinical protocol development and the conduct of human subjects research, along with seminars focusing on basic and laboratory studies and their translation into clinical protocols," NIH adds.

The agency is accepting program applications October 1through mid-January 2012.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.